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Abstract
1. In 2010 a vaccine was licensed for use in badgers in the United Kingdom to  
reduce the severity of Mycobacterium bovis infection, and hence the risks of  
onward transmission to cattle. National legislation was enacted to allow its de-
ployment by lay persons, but the efficiency and feasibility of badger vaccination 
has been the subject of ongoing debate.
2. We conducted quantitative analysis on badger vaccination records and undertook 
interviews and participant observation on a sample of vaccination project partici-
pants in order to investigate (a) progress in the deployment of badger vaccination 
in England, (b) the trapping efficiency and coverage achieved by non-government 
groups, (c) motivations of participants involved in vaccination projects and (d) bar-
riers to wider implementation.
3. Between 2010 and 2015 the number and distribution of vaccine deployment pro-
jects increased substantially, spreading from two to 17 English counties.
4. Estimates of badger trapping efficiency for non-government groups did not differ 
from those achieved by highly experienced government operatives. Our estimate 
of vaccine coverage (i.e. the average proportion of the target badger population 
vaccinated during an operation) was 57% (range 48%–63%).
5. Interviews and participant observation revealed a range of motivations among 
individuals involved in badger vaccination including disease control, demonstra-
tion of an alternative to badger culling and personal or professional development. 
Barriers to wider adoption of badger vaccination expressed by interviewees re-
lated primarily to a perceived lack of confidence among farmers and landowners 
in the effectiveness of badger vaccination for bTB control, but also to the limited 
availability of funding.
6. Our study suggests that badger vaccination led by non-governmental groups is 
practically feasible, and may achieve levels of coverage consistent with disease 
control benefits. Wider uptake of badger vaccination across England might poten-
tially be achieved by addressing the knowledge gap of the effect of badger vacci-
nation on cattle TB, working closely with farmers and vets to better communicate 
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1  | INTRODUC TION
Many diseases of humans and livestock are also shared by wildlife 
and, in some instances, management interventions in wild animal 
populations are required in the interests of public health, agricul-
ture or conservation (Delahay, Smith, Smith, & Hutchings, 2009). In 
some cases, there may be substantial social barriers to implement-
ing these measures. Hence, a cross-disciplinary approach, combin-
ing ecological and social science perspectives, can be valuable in 
understanding the practical challenges of managing disease at the 
interface between wildlife, livestock and human populations (De 
Vos et al., 2016). This may be particularly beneficial where the aim 
is for management to be implemented voluntarily, as understanding 
motivations for involvement and barriers to change, including stake-
holder confidence in the efficacy of a particular approach, become 
pivotal. Indeed, from a pragmatic standpoint, it could be argued that 
in this context stakeholder enthusiasm for an approach is as import-
ant as its efficacy.
Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is a 
chronic disease of cattle, which remains a critical issue in livestock 
farming in many parts of the world, including the United Kingdom 
(Palmer, Thacker, Thacker, Waters, Gortázar, & Corner, 2012). Badgers 
were first identified as a potential source of the disease in UK cattle 
in 1971 (Muirhead, Gallagher, Gallagher, & Bum, 1974) and there has 
since been much debate over how best to manage the risk to livestock. 
Successive governments have commissioned reviews of the scientific 
evidence base and research into the effectiveness of different strate-
gies to control disease risks from wildlife (Bourne et al., 2007; Godfray, 
Donnelly, & Donnelly, 2018; Godfray, Donnelly, Donnelly, Hewinson, 
Winter, & Wood, 2018; Krebs et al., 1997) which essentially comprise 
of badger culling (Jenkins, Woodroffe, Woodroffe, & Donnelly, 2010; 
McDonald, Delahay, Delahay, Carter, Smith, & Cheeseman, 2008), 
biosecurity measures (to reduce interspecies interactions) (Judge, 
McDonald, McDonald, Walker, & Delahay, 2011) and badger vaccina-
tion (Carter et al., 2012; Chambers et al., 2010). Vaccination of cat-
tle is a potential option for the future but is not currently available 
(Chambers et al., 2014; Vordermeier et al., 2002). Despite considerable 
research investment, the relative efficacy of the different approaches 
is not clear and controlling the potential bTB risk posed by badgers 
remains a practically challenging and controversial issue.
Vaccination can contribute to disease control by reducing the 
numbers of either susceptible and/or infectious individuals in a 
population and thereby reducing the number of new infections. 
Intuitively, if badgers are an important source of infection to cattle, 
then reduction in disease incidence in badgers should result in fewer 
new infections in livestock. However, the actual impact of badger 
vaccination on cattle TB incidence remains a significant knowledge 
gap. The UK Government has invested approximately £27 million 
in research and development of badger vaccines against bTB since 
the mid-1990s (Defra, 2018). This resulted in a licensed injectable 
vaccine (BadgerBCG©) which has been shown to reduce the severity 
and progression of disease (and hence excretion of bacilli) in both 
captive (Chambers et al., 2011; Lesellier et al., 2011) and wild bad-
gers (Chambers et al., 2011). Limited Marketing Authorisation for 
BadgerBCG© was granted in 2010 and UK legislation (The Veterinary 
Surgery [Vaccination of Badgers Against Tuberculosis] Order 2010) 
was enacted to allow suitably trained ‘lay vaccinators’ (i.e. non- 
veterinarians) to vaccinate badgers for the purposes of disease con-
trol (Brown, Cooney, Cooney, & Rogers, 2013).
Substantial progress has also been made in relation to the de-
velopment of an oral vaccine for delivery in a palatable bait, akin 
to the highly successful approach taken to vaccinate wildlife against 
rabies in Europe and North America (Cross, Buddle, Buddle, & 
Aldwell, 2007). However, although there is evidence that orally 
administered BCG confers a level of protection against infection 
(Aznar et al., 2018; Chambers et al., 2017) and substantial progress 
has been made with respect to candidate bait and delivery systems 
(Carter et al., 2018; Gowtage et al., 2017; Palphramand et al., 2017; 
Robertson et al., 2016), a licensed oral vaccine is not yet available for 
use. Consequently, capture and injection is currently the only means 
of vaccinating badgers in the United Kingdom, and requires a licence 
issued by governments or their agencies.
Since 2010, a variety of non-government groups have participated 
in badger vaccination, alongside several larger scale government 
operations. Due to increasing interest in badger vaccination by vol-
untary and community sector (VCS) groups, in 2014 the Department 
for Environment, Food and Rural Affairs (Defra, 2014) launched the 
‘Badger Edge Vaccination Scheme’ (BEVS) to provide funds to sub-
sidize vaccination costs in the bTB Edge Area in England (Figure 1). 
BEVS aimed to help create ‘a protected badger population’ between 
the High Risk Area where a relatively high proportion of cattle herds 
are infected with bTB, and the Low Risk Area which has a low inci-
dence of bTB in cattle (Defra, 2014). The scheme provided part fund-
ing to successful projects, including free training and ongoing support 
and advice from government staff, loans of equipment such as traps, 
and vaccine supplies (Defra, 2014). To receive support, vaccination 
the evidence base (in order to increase confidence in badger vaccination as a viable 
disease management approach), and by increased financial support for new initia-
tives and the scaling up of existing projects.
K E Y W O R D S
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projects are required to cover a minimum area of 15 km2 of largely 
contiguous, accessible land.
In 2015, the only company manufacturing BadgerBCG experi-
enced difficulties with production resulting in cessation of vaccine 
supply and as a result BEVS was suspended in 2016. Thus, badger 
vaccination was severely limited in 2016 and 2017. Supply was not 
resumed within the timeframe of this scheme, although use of an 
alternative vaccine (Intervax, BCG Sofia) was authorized under the 
veterinary ‘cascade’ (a means whereby vets are permitted to use their 
clinical judgement to treat animals in accordance with a risk-based 
decision tree) in the interim period. The ‘Badger Edge Vaccination 
Scheme 2’ (BEVS 2) was relaunched in 2018. In addition to funding 
badger vaccination projects via these schemes, Defra subsidized the 
cost of lay vaccinator training (2010–2015) and provided additional 
subsidies to VCS organizations (2012–2014).
Previous research has suggested that landowners and farm-
ers have, in general, little confidence that it is possible to capture 
a sufficient proportion of the badger population to make vaccina-
tion worthwhile (Naylor et al., 2017; Warren, Lobley, Lobley, & 
Winter, 2013). Here we describe the deployment of badger vaccina-
tion in England from the point of licensing in 2010 until 2017 by gov-
ernment and non-government groups including: voluntary groups, 
commercial operators and farmers. We address some of the key 
knowledge gaps on practical aspects of vaccine deployment (Naylor 
et al., 2017), including estimates of trapping efficiency and vaccine 
coverage. Through dialogue with key stakeholders we also explore 
the motivations of groups and individuals participating in vaccina-
tion projects, and the potential barriers to wider implementation.
2  | METHODS
2.1 | Quantitative data sources and analysis
In England, all badger vaccination projects are required to submit 
records of their activities as a condition of the Natural England 
licence under which they operate. These records are held in an SQL 
database hosted by the Animal and Plant Health Agency. The cur-
rent study draws on 7,282 records (the total number of records avail-
able) from 2010 to 2017. A record is defined here as a given night of 
badger trapping in a specific area undertaken by a vaccination group. 
Reported data include numbers of traps deployed, days of trapping, 
badgers captured and doses of BCG vaccine administered. Statistical 
analyses were carried out using GLMM in R version 3.3.2 (R Core 
Development Team, 2016).
2.2 | Injectable vaccine deployment
Badger vaccination involved trapping animals in baited cage traps 
followed by intra-muscular injection of the vaccine (the full process 
is described in Box 1). We mapped the spatial distribution of badger 
vaccine deployment projects in England (2010–2017), aggregated 
by year and vaccination group type (government, commercial op-
erators, landowners, farming sector and VCS). It is assumed that the 
number of doses delivered in any given year equates to the number 
of badgers vaccinated, as each animal was temporarily marked when 
captured to avoid revaccination within the same year (see Box 1).
2.3 | Trapping efficiency
To investigate trapping efficiency during vaccination operations we 
used data on the numbers of traps set and the proportion of traps 
that captured badgers on each trapping night at a particular loca-
tion (e.g. a badger sett, with multiple such locations in each vac-
cination area). A sufficient number of records was only available for 
projects undertaken from 2010 to 2015 inclusive (n = 6,352). Too 
few records were available for operations in 2016 and 2017 be-
cause of an interruption in vaccine supply. To investigate predictors 
of trapping efficiency, we constructed GLMMs using the r package 
lme4 (v1.0–5; Bates, 2010) with a binomial error structure. The re-
sponse variable (trapping efficiency) was the number of traps that 
were occupied (by at least one badger) divided by the total num-
ber of traps set. Operational year (i.e. year of the project, indicating 
F I G U R E  1   Bovine TB risk map for Great Britain (Accessed from 
TBHub website: https://tbhub.co.uk/guida nce/testi ng-and-compe 
nsati on/testi ng-areas / 8 January 2018)
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how long a group had been carrying out vaccination), vaccination 
group type (government or non-government) and calendar month 
were included as fixed effects. Inclusion of operational month in 
the model served to assess whether some months of the open sea-
son for badger trapping (May–November inclusive in England) were 
more favourable than others. Interaction terms were not included 
in the model as the distribution of data was such that certain com-
binations of predictor variables were not represented. Vaccination 
group ID was included as a random effect to account for additional 
variation between different non-government vaccination groups. 
Initial analyses indicated that the models were over-dispersed, so an 
additional record-level random effect was added to control for this 
(Harrison, 2014). The significance of fixed effects was evaluated by 
step-wise model simplification using chi-squared test statistics and 
a threshold for p of 0.05.
2.4 | Vaccine coverage
To estimate coverage in vaccinated areas, it was first necessary to 
estimate the size of the population subject to each trapping opera-
tion. To this end we used the Lincoln–Petersen (LP) index (Lincoln, 
1930; Petersen, 1896) with the Chapman adjustment (Chapman, 
1951), a simple capture–mark–recapture approach that can be used 
to estimate population size based on just two visits: a single capture 
and marking (first night of trapping) and an opportunity for recapture 
(second night of trapping). The assumption underlying this approach 
is that the ratio of marked individuals in the original sample to the 
total population size is the same as the ratio of marked individuals 
to the total sample size in the second sample. We recognize that 
a proportion of the population is likely to evade capture and that 
by this method it is therefore only possible to estimate the size of 
the ‘trappable’ population. Vaccination records were aggregated by 
group and year such that the estimated trappable population size for 
a given group and year = (total vaccinated and marked on 1st night 
of trapping × total trapped on 2nd night of trapping)/(total marked 
badgers trapped on 2nd night of trapping).
We used records from the first and second nights of vaccina-
tion operations only (occasionally trapping was extended to a third 
or fourth night when no badgers were captured on the first two 
nights). As the LP Index is known to be biased by small sample sizes, 
we also excluded data from groups where less than seven marked 
badgers were caught on all second nights of trapping (Robson & 
Regier, 1964) following the recommendation in Robson and Regier 
(1964). In some cases, animals captured on the first night of trap-
ping at a given location were already marked indicating that they 
had been previously trapped and vaccinated as a consequence of a 
separate trapping operation in a neighbouring area. Hence, to avoid 
double counting, any marked animals trapped on the first night of a 
given operation were excluded from the analysis.
We used the ‘fishR’ function within fsa package to estimate the 
trappable population size based on the LP index for all remaining 
vaccination group by year combinations (n = 33), with 95% confi-
dence intervals (Ogle, Wheeler, & Dinno, 2020). In an attempt to 
account for the ‘untrappable’ component of the badger populations 
vaccinated (and thereby get closer to the true population size), we 
adjusted these estimates upwards by 13%, following the recommen-
dations of Smith and Cheeseman (2007). We then estimated vacci-
nation coverage with 95% confidence intervals.
2.5 | Vaccination group motivation and barriers to 
wider vaccine deployment
Here we draw on findings from participant observation of badger 
vaccination and interviews undertaken in 2016 and 2017 as part of 
a wider social research project on bTB ‘disease control’ practices. 
Participant observation was undertaken with a VCS vaccination 
group in the Edge Area of England in summer and autumn 2017. This 
involved two visits (each of 2-3 days) with nine volunteers and two 
badger vaccination group representatives, to document conversa-
tions and practices during badger trapping and vaccination. The 
data considered here are derived from field notes from these visits 
and nine semi-structured interviews with individuals from across 
England who were involved in badger vaccination (see Table 1). The 
aim of the interviews was to learn about opinions and experiences 
related to bTB and hence topics varied depending on the participant, 
but questions related to badger vaccination included: 
• What is your opinion on badger vaccination?
• What are your motivations for taking part (or not taking part) in 
vaccination?
BOX 1 Badger vaccination: An overview of the 
process
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• What has worked well in the badger vaccination project?
• What have been the main challenges you have faced?
• How have you addressed these challenges? Can anything else be 
done?
All field notes (FN 01–05) and interview transcripts (Int 01–09) 
were entered into NVivo (version 11; QSR International Ltd). The 
data were organized into codes and subcategories; for example, the 
‘badger vaccination’ code was categorized by motivations, barriers 
and type of activity. Subsequently, these themes were analysed 
into subthemes. The names of all research participants have been 
changed to preserve their anonymity.
2.6 | Reflections on combined use of 
quantitative and qualitative data sources
The bringing together of two such contrasting sets of empirical data 
in this paper presented a number of challenges to the authorship 
team. For the co-authors who primarily work with quantitative eco-
logical data, a lack of familiarity with methodological approaches, 
presentational and publishing norms when dealing with qualitative 
data represented a key learning opportunity. More broadly, the dif-
fering aims of the research approaches were highlighted; whereby 
quantitative approaches more traditionally employed by ecologists 
involve seeking general patterns, trends and relationships between 
variables whereas social science research seeks to define and under-
stand complexity rather than reduce it (Creswel, 2009). However, 
the contrasting datasets used in this context were directed towards 
a common end; to support decision-making and to facilitate and in-
form the future practice of badger vaccination.
3  | ETHIC AL STATEMENT
Ethical approval for the collection of the qualitative data presented 
in this paper was obtained from Lancaster University, and each par-
ticipant read and signed a consent form. The names of all research 
participants have been changed to preserve anonymity. All badgers 
were trapped under licences issued by Natural England.
4  | RESULTS
4.1 | Progress in injectable vaccine deployment
From 2010–2015, 289 lay vaccinators from 77 vaccination groups 
(see Table 2) received training in badger vaccination procedures 
(no training was undertaken in 2016 and 2017 due to vaccine sup-
ply issues). During this period the number and distribution of vac-
cine deployment projects increased (Figures 2 and 3), spreading 
from two to 17 English counties. Initial deployment of BCG vaccine 
was primarily in the High Risk Area, before spreading into Edge 
Area counties from 2012 onwards (Figure 2). By 2014, badger vac-
cination was being conducted to some extent in the majority of 
the counties within the High Risk Area. In 2015, six vaccination 
groups in the Edge Area received funding from government for 
the deployment of badger vaccination as part of BEVS. A hiatus in 
vaccine deployment occurred in 2016 because of vaccine supply 
issues arising from a global shortage of BCG, with some recovery 
in 2017.
Deployment of BCG vaccine to badgers was initially carried out 
entirely by government (Figure 3 and see also the high numbers of 
vaccine doses delivered in the county of Gloucestershire between 
2010 and 2015), with increasing uptake by non-government organi-
zations from 2011 onwards. Uptake by commercial operators started 
in 2012, but remained relatively low. Landowners and the farming 
sector deployed very few doses of BCG vaccine throughout the en-
tire time period.
Research participant 




participants Data collection method Associated data
Farmer 1 Interview Int 01
Farming representative 2 Interview Int 02 and Int 03
Badger vaccination group 
representative
2 Interview Int 04 and Int 05
2 Interview and participant 
observation




2 Interview and participant 
observation
Int 08, Int 09,  
FN 01–05
7 Participant observation FN 01–05
TA B L E  1   Participants involved in 
interviews and participant observation. 
‘Badger vaccination group representative’ 
refers to the participants who co-
ordinated badger vaccination projects 
and spoke on behalf of the vaccination 
group. ‘Farming representative’ refers to 
the individuals who worked for national 
farmer member organizations
TA B L E  2   Numbers of lay vaccinators receiving training in badger 
vaccination procedures from 2010 to 2015 in each vaccination 
group type
Organization type
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F I G U R E  2   Numbers of vaccine doses delivered to badgers in English counties (2010–2017). Colours indicate Defra bTB risk areas used to 
guide disease control policy in England; the High Risk Area in red, the Low Risk Area in green and the intermediate ‘Edge Area’ in orange (see 
Figure 1 for further detail)
F I G U R E  3   The numbers of doses of BCG administered to 
badgers (equating to the number of badgers vaccinated) per year in 
England, stratified by vaccination group type
TA B L E  3   Summary of outputs from a GLMM to explain variation in 
trapping efficiency (proportion of traps which caught a badger) during 
vaccination operations. Reference levels for the variables, organization 
type and month were government and August respectively
Variable Estimate SE OR χ2 p




−0.54 0.65 0.58 0.68 0.4
Operational 
year
0.18 0.02 1.20 88.7 <0.001
Month
May −0.42 0.13 0.66 208.09 <0.001
June −0.17 0.07 0.84
July 0.14 0.07 1.15
September −0.28 0.07 0.76
October −0.87 0.08 0.42
November −0.73 0.13 0.48
Bold values denote statistical significance at the p < 0.05 level.
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4.2 | Trapping efficiency
On average, across all vaccination group types, 40% of traps de-
ployed on a given trapping night resulted in the capture of a badger. 
Trapping efficiency did not vary significantly between govern-
ment and non-government vaccination groups (χ21 = 0.68, p = 0.40, 
OR = 0.58, Table 3), but generally increased over time (χ21 = 88.70, 
p < 0.001, OR = 1.20, Table 3; Figure 4) and varied between months 
with a peak in June/July and a decline later in the autumn (χ21 = 
208.09, p < 0.001, Table 3; Figure 4).
4.3 | Vaccine coverage
Mean annual vaccine coverage within the trappable badger population 
was estimated to be 65% (range 55%–70%). Correction for the untrap-
pable portion of the population resulted in annual estimates of overall 
coverage of 57% (range 48%–63%). Confidence intervals for estimates 
of the proportion of the population vaccinated were strongly nega-
tively correlated with the sample size (number of records available) 
for a given vaccination group (Spearman's correlation coefficient = 
−0.92, S = 11,460, p < 0.001). This is reflected in the increasing un-
certainty around the estimates for years 2012–2015 during which non-
government vaccination groups, generally operating at a smaller scale, 
contributed a greater number of records to the dataset, compared to 
the relatively narrow confidence intervals around estimates for 2010–
2011 where the dataset is almost entirely comprised of records from 
larger scale government-led vaccination projects (Defra; Figure 5).
4.4 | Motivations of vaccination group 
representatives and vaccination project participants
The motivations of research participants for their initial and ongo-
ing involvement in badger vaccination were summarized into themes 
F I G U R E  4   Temporal variation in trapping efficiency (proportion of traps occupied) during the operational year (Figure 4a) and month 
(Figure 4b) of badger vaccination projects (2010–2015). Points represent the marginal predicted proportion (based on model predictions, 
Table 3) and error bars represent standard deviation around means
F I G U R E  5   Estimated proportion of the trappable population 
vaccinated during badger vaccination projects in England (2010–
2015). The most extreme 95% confidence intervals of estimates 
from a given year are indicated
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(Table 4). Some of these themes are closely aligned to government 
objectives, for example to contribute to the management of bTB, 
while others appeared unrelated to disease management, for exam-
ple to build friendships (Table 4).
In interviews, three badger vaccination group representatives 
(Int 04, Int 05 and Int 06) in the Edge Area spoke of undertaking 
badger vaccination to try to prevent the spread of bTB: 
Well ‘cos what we're really doing is trying to have like 
a prevention, so I can see the benefit for vaccination 
there, in that we don't want it to establish in [Edge 
Area county] (Int 04)
When asked why they wanted to prevent the establishment of 
bTB in the local area, a badger vaccination group representative who 
worked for the Wildlife Trusts said it was to protect the rich biodiver-
sity associated with dairy farming: 
that area that we are doing the vaccination in, you 
know you get different wildlife, you’ve got the nice 
bushy hedgerows, you've got the pasture fields, so it 
does make a difference. So you know we want to sup-
port the dairy farmers there […] ‘cos if their industry 
collapses, it's likely they're then going to turn to ara-
ble which is typically worse for ecosystems (Int 06)
Her motivation for co-ordinating badger vaccination was to pre-
vent the spread of bTB to help the dairy industry remain in the local 
area, thereby reducing the likelihood of the land being used for mono-
culture arable production and protecting the current ecosystems. Her 
motivation to prevent the spread of bTB was linked to the Wildlife 
Trusts’ wider aim of ‘improving life for wildlife and people together’ 
(The Wildlife Trusts, 2018).
Another coordinator of a badger vaccination project said that 
badger vaccination was being undertaken to build relations with 
local farmers in the hope that they may work together in trying to 
manage bTB: 
its kinda strategic. We work together on vaccination, 
build bridges and hey presto, we’ve got relations where 
we can work together to manage TB. We might not share 
the same views, but we share the same aims (Int 06)
The motivation of ‘disease control’ was shared by two farming rep-
resentatives involved in badger vaccination (Int 02, Int 03). They were 
supportive of badger vaccination as a stop-gap until they secured a 
badger culling licence for the local area. During interview, a farming 
representative said: 
We are not against vaccination, it just needs to be 
done the right place at the right time. I worked with 
TA B L E  4   Key motivations of participants in badger vaccination projects, stratified by theme
Broad theme Sub themes Data source Research participant type
Contribution to the 
management of bTB
To reduce the risk of disease transmission 
between badgers and cattle
Int 02, Int 03, Int 04, 
Int 05, Int 06, Int 09, 
FN 01, FN03
Farmer, farming representatives, badger 
vaccination group representatives, volunteers
To protect local cattle Int 02, Int 03, Int 01, 
Int 08, FN 01
Farmer, farming representatives, badger 
vaccination group representatives, volunteers
To protect own livestock Int 01 Farmer
To protect badgers from spread of bTB Int 04, Int 09, FN 01, 
FN03




To demonstrate that vaccination can 
be undertaken cost effectively with 
volunteers




To provide a stop-gap until a cattle 
vaccine is licensed
Int 01 Farmer
To provide landowners with an alternative 
to culling
Int 02, Int 03 Farming representatives
To influence government policy Int 04, Int 05, Int 06, 
Int 09, FN 01, FN03





To spend time outside FN 04 Volunteer
To see badgers in the wild close up FN 04 Volunteer
Personal satisfaction FN 04, Int 08 Volunteer
To build friendships Int 08 Volunteer
To use spare time in retirement FN 04 Volunteer
To gain work experience FN 04 Volunteer
Societal benefits To build relationships with farmers Int 06 Badger vaccination group representative
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the Wildlife Trusts ‘cos there was no other tool in the 
box, culling wasn't on the table. I got folk involved in 
vaccination to try to control this bloody disease until 
we get a cull (Int 03)
However, motivations for being involved in badger vaccination var-
ied between representatives involved in the same projects. A badger 
vaccination group representative working on the same project as Int 
03 stated that he was leading a vaccination group to prove that it was 
a viable alternative to badger culling: 
we have such a big land holding that we could be 
sure that we'd have enough space to do it and es-
pecially in an area where it seemed that TB was an 
issue. It's very close, we're on the border of High Risk 
and Edge Area. So yeah there's knowing we had the 
land, knowing that TB was an issue, and we still have 
a policy of we wouldn't permit any culling of badgers 
on our land, so if we’ve got a lot of land with a lot of 
badgers and there's a TB issue, it's a perfect one for 
us to show that badger vaccination's a viable alterna-
tive (Int 04)
A Wildlife Trusts badger vaccination group representative ex-
pressed a similar motivation for leading a vaccination project: 
we were very very keen to show that vaccination was 
an alternative to culling that was doable, and in saying 
that we wouldn't let people cull any badgers on our 
estate (Int 05)
This aligns with the Wildlife Trusts’ stated motivation to ‘demon-
strate the viability of badger vaccination as part of a wider set of mea-
sures to tackle bovine Tuberculosis (bTB) in cattle’ (The Wildlife Trusts, 
2014). Another badger vaccination group representative who worked 
for the Wildlife Trusts said: 
We’ve developed a model of how vaccination can be 
achieved in a cost-effective professional programme 
using volunteers (Int 07)
He was proud of what the local group had achieved and hoped 
their work would inspire more Wildlife Trusts to conduct badger vac-
cination. Motivations related to disease control, building relations with 
local farmers and proving the effectiveness of vaccination were also 
shared by volunteers. For example, four volunteers (Int 08, Int 09, FN 
01 and FN 03) said they became involved in badger vaccination to re-
duce the risk of disease transmission between badgers and cattle, with 
the hope that their actions would influence government to be more 
supportive of vaccination rather than badger culling: 
When setting the traps, I worked with someone who 
told me it feels like a worthwhile project because he 
can see the result of his actions. He also said that if 
their vaccination programme is successful, it could 
influence policy and stop culling. He wants to know 
whether vaccination has an effect on TB, although 
he recognised that this is hard to do in practice. He 
said that this is his measure of success: if all the bad-
gers are vaccinated and there is no effect on cattle 
TB then it should lead to questioning of cross spe-
cies transmission, if there is an effect it shows that 
vaccination works. It seemed like a win-win situation 
as he had total faith that vaccination was ‘effective’ 
(FN 03)
For some volunteers, their motivations had changed over time. 
Two research participants went on to say that reducing the risk of 
disease transmission was no longer a motivation for their continued 
involvement because they did not feel that their actions (following 
involvement in vaccination for over 5 years) had influenced govern-
ment policy or local landowner's attitudes to vaccination (Int 08, 
FN 05). In response to a question about her current motivations for 
being a lay vaccinator, an interviewee said: 
I did vaccination training to try to protect cattle 
round here from TB and to stop the [badger] cull. I 
didn't want the cull here as I know it's pointless, and 
I wanted to show my farming neighbours that there's 
an alternative way [to manage the disease] (sighs). 
Ha, how naïve. The cull is getting closer and closer 
and vaccination has made no difference to their [local 
farmers’] attitudes. To be honest, I do badger vaccina-
tion as I count you all as my friends […] I don't socialise 
or do much other than badger vaccination (Int 08)
Interestingly, personal and professional development motiva-
tions for participating in badger vaccination were widely shared by 
volunteers. A veterinary student, who deployed and baited traps for 
badgers, said that he was involved to gain relevant experience of 
working with wild animals (FN 04). Other volunteers derived great 
satisfaction in seeing badgers in the wild ‘close up’ and said that vac-
cination had enabled them to develop an intimate relationship with 
the local countryside (Int. 08, Int 09, FN 02). The following reflexive 
field note was taken after 2 days of participant observation on a bad-
ger vaccination project: 
People said how much they enjoyed being part of the 
vaccination programme to meet other people and 
get up close to a badger. No one said that they were 
taking part to reduce TB in the badger population or 
protect the local badger/cattle population. It was as 
though TB was irrelevant to the act of vaccinating 
badgers. Their core reason for taking part in vaccina-
tion did not seem to be the governmental reason for 
vaccinating (FN 02)
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4.5 | Barriers to wider implementation
The perceived barriers to badger vaccination, as identified by re-
search participants were also summarized into themes (Table 5).
Badger vaccination group volunteers and representatives fre-
quently mentioned farmer/landowner attitudes towards vaccination 
as a barrier to wider implementation (FN 03, FN 04, Int 06, Int 07, 
Int 04). Volunteers working on badger vaccination with the Wildlife 
Trusts or Badger Groups suggested that farmers consider badger 
vaccination as ‘wildlife protection’ which acted as a barrier to their 
involvement. Research participants perceived that farmers do not 
generally consider wildlife groups to be involved in disease manage-
ment, and that their involvement as wildlife and conservation groups 
undermines farmers’ trust in badger vaccination as a disease man-
agement tool: 
farmers do not understand us [volunteers in the badger 
group doing badger vaccination] and perceive us to be 
tree huggers. I'm a full-time volunteer doing a lot of jobs 
for this registered charity! Yet, I'm ridiculed. It’s incredi-
bly insulting and incredibly demoralising […] They think 
vaccination is wildlife, not disease, protection (Int 08)
A badger vaccination group representative said that he had expe-
rienced resistance to badger vaccination from local farmers because 
they were more supportive of badger culling: 
he's very much like a lot of farmers I meet and that, he 
maybe thought that vaccination was not the best op-
tion, go for the old fashioned option of ‘if it's a prob-
lem get rid of it’ (Int 05)
As described above, one farming representative in the Edge Area 
was motivated to undertake badger vaccination in the local area when 
he thought badger culling was not an option (Int 03). Subsequently, he 
discovered that the area could apply for a cull and was concerned that 
badger vaccination would become a barrier to securing a licence from 
government to do so: 
Now we can cull in the Edge Area and I thought bol-
locks, if I've blocked farmers from having a cull now 
in that area, they're not going to be very popular to 
me. I'll only support vaccination if it doesn't affect our 
chance of getting a cull. It's a stop gap to help reduce 
the chance of disease spread until we can cull (Int 03)
Multiple participants cited a lack of evidence on the effects of bad-
ger vaccination on bTB in cattle as a barrier to farmer involvement (FN 
01, FN 03, Int 04, Int 02), and one farming representative confirmed 
that this was a barrier to his participation: 
we don't have evidence about the impact of badger 
vaccination on TB in cattle like we do for culling. We 
TA B L E  5   Perceived barriers to wider implementation of badger vaccination expressed by project participants, stratified by theme
Broad theme Subtheme Associated data Research participant type
Limited funding available 
for badger vaccination
Partial funding from government available for some 
groups in the Edge Area, but remaining costs of 
vaccination projects need to be covered
FN 01, Int 04,  
Int 05, Int 06




Perceptions of lay vaccinators by landowners Int 08 Volunteer
Time required to build relationships with landowners to 
sign them up for vaccination projects
Int 06 Badger vaccination group 
representative
Building up contiguous areas of signed up land to meet 
vaccination licence criteria
FN 04, FN 05 Badger vaccination group 
representative, volunteers
Badger vaccination as a stop-gap to culling prevented 
long-term investment in projects
Int 03 Farming representative
Low confidence in 
badger vaccination by 
farming community and 
landowners
Lack of evidence on the impact of badger vaccination on 
cattle bTB
FN 01, FN 03,  
Int 02, Int 04
Farming representative, 
badger vaccination group 
representatives, volunteers
Concerns of a negative link between badger vaccination 
and cattle herd breakdowns
Int 01 Farmer
Conflict between badger 
culling and vaccination
Comparing vaccination with culling Int 01, Int 02, Int 03 Farmer, farming 
representatives
Practical constraints Interruptions in vaccine supply FN 04 Badger vaccination group 
representative
Availability of volunteer workforce Int 04 Badger vaccination group 
representative
Government policy Vaccination groups have no information on the locations 
of cull zones and do not want to vaccinate badgers if 
the badgers could subsequently get shot in a nearby cull 
zone
FN 01 Badger vaccination group 
representatives, volunteers
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need a big field trial. Until I have evidence in front of 
me that badger vaccination definitely reduces TB in 
cattle, I'm not gonna bother it (Int 02)
Practical issues were also identified as barriers to the expansion 
and continuation of badger vaccination. One vaccination group repre-
sentative stated that the interruption to supply of BadgerBCG in 2016 
had created a barrier to farmers remaining involved: 
G told me that one of the farmers in the vaccination 
programme was unsure whether to continue allowing 
vaccination on his land in 2017. No vaccination had 
taken place on his land in 2016 due to the vaccine 
shortage, and the group were using Intervax in 2017. 
He was concerned whether the use of Intervax vaccine 
would affect the future use of BadgerBCG vaccine. He 
wanted to know there was no adverse reaction be-
tween the vaccines before he allowed the group to use 
Intervax on the badgers on his land (FN 04)
In addition, practical issues related to badger vaccination were con-
sidered to be obstacles to the involvement of farmers. One vaccination 
group representative (H) said she was proactively changing the prac-
tice of badger vaccination to be less intrusive to the landowner to try 
to make it more attractive to local farmers: 
Next year, H says they will not do the activity sur-
vey before pre-baiting, but rather will do it when they 
pre-bait. This reduces activity onto the farm and is 
therefore less intrusive to landowners. H said that 
the land owners have a lot of people going onto their 
land- walkers, bikers etc. - so they want to keep activ-
ity on the farm to a minimum so as not to disrupt the 
farmer (FN 01)
Barriers to uptake of vaccination unrelated to the involvement of 
farmers were also discussed. For example, multiple groups struggled to 
source funding to undertake badger vaccination (FN 01, Int 04, Int 05, 
Int 06). Although six groups in the Edge Area secured partial funding 
from Defra under the BEVS, they had to secure the remaining funds 
themselves through public appeals, fund-raising events, charging farm-
ers for vaccination and using central charity funding (Int 05, Int 06, FN 
05). A vaccination group representative in the Edge Area was not keen 
to charge farmers: 
We can't charge farmers for vaccination as many 
won't pay. Many are only agreeing to vaccination until 
they get a cull. Charging them for the service will be 
a sure fire way to reduce the number of sites where 
we can vaccinate! Saying that, a few large estates are 
ok paying for peanuts. It's just I don't know who will 
say yes and who will say no, and I don't want to make 
vaccination even more unattractive to them (Int 05)
Demotivation of volunteers arising from the expansion of the bad-
ger cull across England was identified as another barrier to further 
uptake of badger vaccination. While baiting cages in preparation for 
vaccination, a volunteer stated that she wanted to vaccinate to prevent 
a badger cull in the local area, but did not want to vaccinate badgers 
only for them to be subsequently shot: 
There are currently nine farmers wanting the group to 
vaccinate on their land. G is keen to expand the vac-
cination area for BEVS 2. However, she is concerned 
about what would happen if a cull was licensed in the 
area. She wants to vaccinate in order to prevent a cull 
in the area, but does not want to vaccinate and then 
the badgers to be shot (FN 01)
5  | DISCUSSION
Although badger vaccination has been available as a tool for bTB 
control since 2010, and despite substantial financial investment in 
its development by government, deployment in the field has been 
relatively small scale to date (Figure 2). Nevertheless, our results 
demonstrate that following licensing in 2010, there was an increase 
in uptake accompanied by a gradual change in the geographic dis-
tribution of projects and in the types of groups involved. Initially 
badger vaccination was government-led and concentrated in parts of 
the HRA, but this changed to being principally volunteer/community 
organization led, with small projects in the majority of counties in 
both the HRA and Edge Area. To date, outside government, badger 
vaccination has been conducted primarily by VCS groups. The inter-
ruption in vaccine supply in late 2015 is likely to have been a key 
factor in limiting the scale of vaccination effort in subsequent years.
The UK government commissioned an independent review of 
bovine TB policy which concluded in 2018 (Godfray, Donnelly, & 
Donnelly, 2018; Godfray, Donnelly, Donnelly, et al., 2018) and have 
recently issued their response to the review findings (Defra, 2020). 
Badger vaccination is heavily referenced throughout the response 
including a desire to gradually replace intensive culling of badgers 
with Government supported badger vaccination over the com-
ing years. The findings of the present paper are particularly timely 
therefore in supporting these goals which are important contribu-
tors to the government's stated aim of achieving Officially TB Free 
status for England by 2038 (Defra, 2020).
Previous research suggests that landowners and farmers have, 
in general, little confidence that it is possible to capture a sufficient 
proportion of the badger population to make vaccination worthwhile 
(Naylor et al., 2017; Warren et al., 2013). Data from the present 
study however indicated that on average, levels of trapping effi-
ciency did not consistently differ between operations led by highly 
experienced government staff and non-government-led operations. 
This suggests that the training framework and the ongoing support 
system offered by government experts to lay vaccinator groups has 
been generally effective. Trapping efficiency for volunteer groups 
12  |    People and Nature BENTON ET al.
increased over time, probably owing to a number of factors, not least 
of which is likely to be the gradual improvement of staff field skills 
and increasing knowledge of the target population (number of bad-
gers caught at each sett in previous years etc.). Annual variation in 
trapping efficiency may reflect badgers becoming habituated to the 
trapping process over time (Griffiths, 2011) or a gradual increase in 
the skill or experience of trappers. Our results also indicate seasonal 
variation in trapping efficiency which was highest in July and lowest 
in November. Lower availability of natural foods (Garnett, Delahay, 
Delahay, & Roper, 2002; Tolhurst, Delahay, Delahay, Walker, Ward, 
& Roper, 2009) and the presence of cubs (which tend to be more 
likely to be captured than adults, Tuyttens et al., 1999) in summer 
may explain such seasonal variations.
The results of a recent field trial in the Republic of Ireland sug-
gested vaccination of over 30% of the target badger population with 
an oral vaccine would make eradication of bTB feasible, given main-
tenance of existing cattle controls (Aznar et al., 2018). Estimates of 
annual vaccination coverage from the present study exceeded 50% of 
the target population (average 57%, minimum annual estimate 48%). 
This is consistent with an estimate for vaccine coverage of 55% (95% 
CI – 44%–65%) achieved in a single year of a Welsh Government led 
program of vaccination by trapping and injection (Smith et al., 2017). 
The latter study used hair traps to remotely sample the background 
badger population (thereby circumventing issues around trappability) 
and derived coverage by matching the genotype of vaccinated ani-
mals to the hair-trapped population. The methods employed in the 
present study have a number of important limitations. Firstly, when 
calculating the trappable population size we excluded records for 
which trapping extended beyond two nights and groups for which the 
number of recaptured badgers was low. This means that the remain-
ing dataset may have been biased towards more successful trapping 
operations and larger social groups. A proportion of animals captured 
during the first night of trapping at a given site were already marked 
indicating they had been trapped elsewhere previously and subse-
quently moved between trapping locations. These records were 
necessarily excluded when calculating the LP Index. By extension, 
it is reasonable to assume that a proportion of animals identified as 
being marked on second night of trapping had also previously been 
trapped at a different site, although we had no way of identifying 
these animals. There is therefore potential for the same animal to be 
recorded as a recapture at multiple sites which could artificially in-
flate estimates of vaccine coverage. In addition, because vaccination 
groups can operate at any time during the designated season (May 
to November in England), there may be an interval of several months 
between trap rounds, after which time hair clips and temporary stock 
marker applied to vaccinated animals (see Box 1) may no longer be 
visible. This raises the potential for some previously vaccinated ani-
mals to go undetected which would lead to an underestimate of pop-
ulation coverage. Perhaps most importantly, by calculating LP index 
estimates of annual population size at the vaccination group level, the 
implicit assumption is that the target population is closed. Given that 
we have evidence of animals moving between individual trapping lo-
cations, we can be confident that movement of animals into and out 
of the vaccinated area also occurred over the course of the vaccina-
tion season, thereby undermining a key assumption of the LP index. 
Animals may also have been lost to the population through mortal-
ity, although births are unlikely due to the timing of the vaccination 
season. Consequently, estimates of vaccination coverage presented 
in this study, while encouraging, should be interpreted with caution. 
More broadly, it should also be noted that the proportion of the pop-
ulation vaccinated is only one component of success in a vaccination 
campaign; the immune response elicited by the vaccine and the epi-
demiological consequences of vaccination are also key requirements 
for a balanced evaluation of the effectiveness of badger vaccination 
as a management strategy (Chambers et al., 2014).
Previous studies have explored farmers’ views in relation to 
badger vaccination for the purpose of bTB control (Enticott, Maye, 
Maye, Fisher, Ilbery, & Kirwan, 2014; Enticott, Maye, Maye, Ilbery, 
Fisher, & Kirwan, 2012; Naylor et al., 2017) but to our knowledge, 
this study is the first attempt to examine the motivations of individ-
uals participating in vaccination projects. Our findings suggest that 
badger vaccination group representatives and participating individ-
uals are motivated by a range of factors, some of which relate di-
rectly to disease management while others may have a political (e.g. 
trying to influence current government policy) or personal basis. All 
vaccination group representatives stated they were, at least in-part, 
motivated to prevent the spread of disease into their local area. This 
motivation strongly aligns with Defra's aim to fund vaccination proj-
ects in the Edge Area ‘to support the creation of a protected badger 
population in uninfected areas’ (Defra, 2014, p. 1). Many volunteers 
were also motivated to undertake badger vaccination for the pur-
pose of disease control; however, this was often related to trying 
to prevent culling. Volunteers were also motivated by other factors 
unrelated to bTB, for example to gain work experience and build 
friendships. The expansion of badger vaccination across the country 
by VCS groups has likely led to more volunteers being involved for 
reasons unrelated to disease control. Many vaccination projects rely 
on volunteers, and so it follows that motivations unrelated to disease 
control may be important to the overall success of these initiatives.
In this study, individuals involved in badger vaccination identi-
fied barriers to its wider deployment related to low levels of confi-
dence in its efficacy among landowners and farmers. Furthermore, 
a farming representative expressed scepticism about the efficacy 
of vaccination due to the absence of data from a large-scale field 
trial. Reporting on telephone interviews with 341 farmers (Enticott 
et al., 2012) state that 61% of farmers disagreed with the statement 
that ‘Vaccinating badgers is better than culling badgers to control 
bTB’. Furthermore, in the present study we identified a percep-
tion that badger vaccination may reduce the likelihood of securing 
a cull licence for a given area, potentially creating another barrier 
to farmers and landowners supporting vaccination. An empirical 
demonstration of the effects of badger vaccination on the levels of 
bTB in cattle may help to inform the debate about bTB control in 
badgers (Godfray, Donnelly, & Donnelly, 2018; Godfray, Donnelly, 
Donnelly, et al., 2018) and, dependent on the results, could help to 
reduce scepticism about badger vaccination. Interviews with VCS 
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groups in the present study also identified cost as a potential barrier 
to the expansion of badger vaccination, with several groups strug-
gling to finance projects despite partial funding from Government. 
Gloucestershire Wildlife Trust estimate that the average cost of 
vaccination in their VCS led project was £264/badger vaccinated 
(Gloucestershire Wildlife Trust, 2015).
Only limited badger vaccination has been carried out by farmers or 
landowners themselves, consistent with a general lack of confidence 
within the farming community (Enticott et al., 2014, 2012; Naylor 
et al., 2017). This translates into a general unwillingness in the farm-
ing community to pay for badger vaccination (Enticott et al., 2014; 
O'Hagan, Matthews, Matthews, Laird, & McDowell, 2016), which 
was identified in the present study as a barrier to wider implemen-
tation of badger vaccination for VCS groups and is presumably also 
a key factor in the very limited interest from commercial operators. 
The absence of any long-term investment in badger vaccination by 
farmers may be, at least in part, because it is viewed as a ‘stop-gap’ 
until a culling licence can be secured (Int 02 and Int 03). The present 
study identified potential expansion of badger culling into vaccina-
tion areas as demotivating for volunteers, limiting their ambitions to 
expand vaccination projects over larger areas.
The results of the present study demonstrate that it is possible 
to train significant numbers of lay badger vaccinators, and to ex-
pect that levels of vaccination coverage and efficiency achieved by 
non-government-led groups to be comparable to government oper-
ations. We conclude that non-government-led badger vaccination 
is therefore practically feasible, and could potentially contribute to 
bTB control in badgers. However, the current scale of badger vacci-
nation projects is limited and we have identified multiple barriers to 
its expansion. Initiatives that might be expected to facilitate further 
uptake of badger vaccination for bTB control include increasing the 
availability of financial support, an empirical demonstration of the 
impact of badger vaccination on levels of disease in cattle and work-
ing closely with farmers, and vets, to disseminate the evidence to 
date and increase confidence in badger vaccination.
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